tirzepatide grey forum PART II: The Gray Market of Compounded GLP1 Injections — A Dangerous A – Town & Country Compounding New Pricing, Access to Tirzepatide

Regular eye examinations are recommended to detect any changes early

Mounjaro (tirzepatide) is a once-weekly injectable medication licensed in the UK for the treatment of type 2 diabetes

GLP-1 and GIP-based therapies may be appropriate for individuals with Type 2 diabetes, insulin resistance, or those who are overweight (BMI 2730+) with at least one weight-related condition such as high blood pressure, high cholesterol, sleep apnea, or cardiovascular disease

Lingvay I, Sumithran P, Cohen RV, le Roux CW

Medical contraindications: Tirzepatide is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC), in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN2), and in those with serious hypersensitivity to tirzepatide

those same effects that help with appetite and glucose control also rearrange how your body handles food, so individual experiences vary